SYRE
#1050
Spyre Therapeutics, Inc. - Common Stock
82.7 8 USD
-0.04%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-3.63%
Variazione Mensile
-8.63%
Variazione di 6 mesi
+24.56%
Variazione Annuale
+246.21%
Chiusura Precedente
85.9 0
Open
85.1 3
Minimo
82.2 4
Massimo
85.3 2
Financials
2024
Current report, 09 May 2024
Spyre Therapeutics, Inc. current report, 09 May 2024
8-K
Current report, 23 Apr 2024
Spyre Therapeutics, Inc. current report, 23 April 2024
8-K
Quarterly report, Q1 FY2024
Spyre Therapeutics, Inc. quarterly report, Q1 FY2024
10-Q
Current report, 18 Mar 2024
Spyre Therapeutics, Inc. current report, 18 March 2024
8-K
Current report, 29 Feb 2024
Spyre Therapeutics, Inc. current report, 29 February 2024
8-K
Current report, 01 Feb 2024
Spyre Therapeutics, Inc. current report, 01 February 2024
8-K
Current report, 16 Jan 2024
Spyre Therapeutics, Inc. current report, 16 January 2024
8-K
2023
Annual report, FY2023
Spyre Therapeutics, Inc. annual report, FY2023
10-K
Current report, 07 Dec 2023
Spyre Therapeutics, Inc. current report, 07 December 2023
8-K
Current report, 22 Nov 2023
Spyre Therapeutics, Inc. current report, 22 November 2023
8-K